Your browser doesn't support javascript.
loading
Corrigendum to "Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy" [Neuromuscular Disorders, Vol. 30 (6) 2020, 492-502].
Wagner, Kathryn R; Abdel-Hamid, Hoda Z; Mah, Jean K; Campbell, Craig; Guglieri, Michela; Muntoni, Francesco; Takeshima, Yasuhiro; McDonald, Craig M; Kostera-Pruszczyk, Anna; Karachunski, Peter; Butterfield, Russell J; Mercuri, Eugenio; Fiorillo, Chiara; Bertini, Enrico S; Tian, Cuixia; Statland, Jeffery; Sadosky, Alesia B; Purohit, Vivek S; Sherlock, Sarah P; Palmer, Jeffrey P; Binks, Michael; Charnas, Lawrence; Marraffino, Shannon; Wong, Brenda L.
Afiliação
  • Wagner KR; Center for Genetic Muscle Disorders, Baltimore, Kennedy Krieger Institute, Departments of Neurology and Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: wagnerk@kennedykrieger.org.
  • Abdel-Hamid HZ; University of Pittsburgh, Pittsburgh, PA, USA.
  • Mah JK; Cumming School of Medicine, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada.
  • Campbell C; Department of Pediatrics, Clinical Neurological Sciences and Epidemiology, University of Western Ontario, Children's Hospital London Health Sciences Centre, London, ON, Canada.
  • Guglieri M; The John Walton Muscular Dystrophy Research Centre, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Muntoni F; NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, & Great Ormond Street Hospital Trust, London, UK.
  • Takeshima Y; Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
  • McDonald CM; Lawson Health Research Institute: Children's Hospital, London, ON, Canada.
  • Kostera-Pruszczyk A; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Karachunski P; University of Minnesota, Minneapolis, MN, USA.
  • Butterfield RJ; University of Utah School of Medicine, Salt Lake City, UT, USA.
  • Mercuri E; Paediatric Neurology, Catholic University, Rome, Italy; Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Fiorillo C; IRCCS Giannina Gaslini, Genova, Italy.
  • Bertini ES; Bambino Gesu Children's Research Hospital IRCCS, Rome, Italy.
  • Tian C; Cincinnati Children's Hospital Medical Center; College of Medicine University of Cincinnati, Cincinnati, OH, USA.
  • Statland J; University of Kansas Medical Center, Kansas City, KS, USA.
  • Sadosky AB; Pfizer Inc, New York, NY, USA.
  • Purohit VS; Pfizer Inc, Cambridge, MA, USA.
  • Sherlock SP; Pfizer Inc, Cambridge, MA, USA.
  • Palmer JP; Pfizer Inc, Cambridge, MA, USA.
  • Binks M; Pfizer Inc, Cambridge, MA, USA.
  • Charnas L; Pfizer Inc, Cambridge, MA, USA.
  • Marraffino S; Pfizer Inc, Cambridge, MA, USA.
  • Wong BL; University of Massachusetts Medical School, Worcester, MA, USA.
Neuromuscul Disord ; 31(2): 167-168, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33451933
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article